Accelerate Diagnostics Inc (OQ:AXDX)

Business Focus: Advanced Medical Equipment & Technology

Aug 06, 2020 04:15 pm ET
Accelerate Diagnostics Reports Second Quarter 2020 Financial Results & Announces New Product Offering
TUCSON, Ariz., Aug. 6, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2020. ...
Jul 16, 2020 08:00 am ET
Accelerate Diagnostics Schedules Call to Review Second Quarter 2020 Results
TUCSON, Ariz., July 16, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 6, 2020 at 4:30 p.m. Eastern Time to review 2020 second quarter financial results....
Jun 15, 2020 09:20 am ET
Faruqi & Faruqi, LLP is Investigating Accelerate Diagnostics, Inc. (AXDX) on Behalf of its Shareholders
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Accelerate Diagnostics, Inc. (“Accelerate Diagnostics” or the “Company”) (NASDAQ: AXDX). The investigation focuses on whether the Company’s...
May 07, 2020 04:01 pm ET
Accelerate Diagnostics Announces First Quarter Financial Results and Provides COVID-19 Business Updates
TUCSON, Ariz., May 7, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced financial results for the quarter ending March 31, 2020 and provided a business update regarding the impact of the ongoing COVID-19 pandemic on the Company's operations....
Apr 15, 2020 05:08 pm ET
Accelerate Diagnostics Announces Preliminary First Quarter Financial Results and Provides COVID-19 Business Updates; Schedules First Quarter 2020 Financial Results Conference Call for May 7, 2020
TUCSON, Ariz., April 15, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced preliminary financial results for the quarter ending March 31, 2020 and provided a business update regarding the impact of the ongoing COVID-19 pandemic on the Company's operations. The Company also announced that it will report full results for the quarter ending March 31, 2020 after the market close on Thursday, May 7, 2020....
Apr 15, 2020 05:07 pm ET
Accelerate Diagnostics and BioCheck Announce Commercial Supply and Collaboration Agreement to Distribute MS-FAST Chemiluminescence Immunoassay Analyzer and SARS-CoV-2 Antibody Tests
TUCSON, Ariz., April 15, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that they have entered into a commercial supply and collaboration agreement. Under the agreement, Accelerate Diagnostics will distribute the BioCheck MS-FAST, a fully-automated chemiluminescence immunoassay analyzer, along with BioCheck's SARS-CoV-2 tests for the detection of IgG and IgM antibodies. The agreement covers North America, Europe and the Middle East. ...
Nov 07, 2019 03:01 pm ET
Accelerate Diagnostics Reports Third Quarter 2019 Financial Results
TUCSON, Ariz., Nov. 7, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2019. ...
Nov 04, 2019 06:45 am ET
Accelerate Diagnostics Appoints Roland Diggelmann to its Board of Directors
TUCSON, Ariz., Nov. 4, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced that Roland Diggelmann has been appointed to its Board of Directors. ...
Oct 17, 2019 08:00 am ET
Accelerate Diagnostics Schedules Call to Review Third Quarter 2019 Results
TUCSON, Ariz., Oct. 17, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that it will report financial results for the third quarter of 2019 after the market close on Thursday, November 7, 2019. The company's management will host a conference call at 4:30 p.m. ET that same day to review the results....
Oct 03, 2019 08:00 am ET
Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes
TUCSON, Ariz., Oct. 3, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. today announced presentation of full data from three outcome studies at IDWeek™ 2019. The full data being presented build upon the high-level findings that were first reported in the Company's September 18, 2019 press release. ...
Sep 18, 2019 07:30 am ET
Accelerate Diagnostics Highlights Clinical Endpoints Achieved Across Mayo Clinic/UCLA, University of Iowa, and UAMS Studies
TUCSON, Ariz., Sept. 18, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the release of positive results from three clinical studies on the Accelerate Pheno™ system that will be presented at IDWeek™ 2019. ...
Aug 08, 2019 04:06 pm ET
Accelerate Diagnostics Names Jack Phillips Chief Operating Officer
TUCSON, Ariz., Aug. 8, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Jack Phillips has been appointed Chief Operating Officer.  Mr. Phillips joins Accelerate from Roche Diagnostics, the world's leading diagnostics company....
Aug 08, 2019 04:01 pm ET
Accelerate Diagnostics Reports Second Quarter 2019 Financial Results
TUCSON, Ariz., Aug. 8, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter ended June 30, 2019. ...
Jul 08, 2019 08:30 am ET
Accelerate Diagnostics Schedules Call to Review Second Quarter 2019 Results
TUCSON, Ariz., July 8, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that it will report financial results for the second quarter of 2019 after the market close on Thursday, August 8, 2019. The company's management will host a conference call at 4:30 p.m. ET that same day to review the results....
May 24, 2019 12:45 pm ET
Accelerate Diagnostics to Present at the William Blair Growth Stock Conference on June 6, 2019
TUCSON, Ariz., May 24, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that Chief Executive Officer, Larry Mehren, and Chief Financial Officer, Steve Reichling will present at the 39th Annual William Blair Growth Stock Conference on Thursday, June 6, 2019 at 12:00 p.m. Central Time....
May 09, 2019 04:01 pm ET
Accelerate Diagnostics Reports First Quarter 2019 Financial Results
TUCSON, Ariz., May 9, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter ended March 31, 2019....
Apr 26, 2019 11:44 am ET
Accelerate Diagnostics Schedules Call to Review First Quarter 2019 Results
TUCSON, Ariz., April 26, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced that it will report financial results for the first quarter of 2019 after the market close on Thursday, May 9, 2019. The Company's management will host a conference call at 4:30 p.m. ET that same day to review the results....
Mar 08, 2019 02:38 pm ET
Accelerate Diagnostics to Present at the Cowen and Company 39th Annual Health Care Conference on March 13, 2019
TUCSON, Ariz., March 8, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that the company is scheduled to present at the Cowen and Company 39th Annual Health Care Conference in Boston on Wednesday, March 13, 2019 at 8:40 AM Eastern Time....
Feb 19, 2019 03:01 pm ET
Accelerate Diagnostics Reports 2018 Fourth Quarter and Full-Year Financial Results
TUCSON, Ariz., Feb. 19, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced financial results for the fourth quarter and fiscal year ended December 31, 2018.  ...
Feb 08, 2019 07:50 am ET
Factors of Influence in 2019, Key Indicators and Opportunity within New Relic, Clean Harbors, Sage Therapeutics, Accelerate Diagnostics, Fortinet, and Colfax — New Research Emphasizes Economic Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of New Relic, Inc. (NYSE:NEWR), Clean Harbors, Inc. (NYSE:CLH), Sage...
Feb 05, 2019 03:03 pm ET
Accelerate Diagnostics schedules call to review 2018 fourth quarter and full-year results
TUCSON, Ariz., Feb. 5, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Tuesday, February 19, 2019 at 4:30 p.m. Eastern Time to review 2018 fourth quarter and full-year financial results....
Jan 02, 2019 03:48 pm ET
Accelerate Diagnostics to Present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco
TUCSON, Ariz., Jan. 2, 2019 /PRNewswire/ -- Accelerate Diagnostics announced today that the company is scheduled to present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019, at 2:30 PM Pacific Time....
Nov 27, 2018 06:12 am ET
Accelerate Diagnostics Pledges Matching Support for Sepsis Alliance #GivingTuesday Movement to Raise Awareness of Sepsis as a Medical Emergency
TUCSON, Ariz., Nov. 27, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. has joined with Sepsis Alliance to celebrate #GivingTuesday, November 27th, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity worldwide....
Nov 09, 2018 07:45 am ET
Analysis: Positioning to Benefit within CSS Industries, Accelerate Diagnostics, Oasis Petroleum, Model N, Carbonite, and Masonite International — Research Highlights Growth, Revenue, and Consolidated
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CSS Industries, Inc. (NYSE:CSS), Accelerate Diagnostics, Inc....
Nov 06, 2018 03:01 pm ET
Accelerate Diagnostics reports Q3 2018 financial results
TUCSON, Ariz., Nov. 6, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending September 30, 2018.  The company reported a 40% increase in U.S. instruments placed under commercial contract, and revenue for the quarter of $1.3 million, an increase of 64% from the prior year quarter. Worldwide, revenue-generating instruments combined with those under evaluation agreements grew to 458 instruments....
Oct 17, 2018 04:51 pm ET
Accelerate Diagnostics to Review Third Quarter 2018 Results on November 6th
TUCSON, Ariz., Oct. 17, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that it will host a conference call on Tuesday, November 6, 2018 to review the company's third quarter 2018 financial results and commercial progress. ...
Oct 15, 2018 09:20 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within Meritor, Fred's, Arena Pharmaceuticals, AMERISAFE, Accelerate Diagnostics, and NextEra Energy — New Research Emphasizes Economic Gro
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Meritor, Inc. (NYSE:MTOR), Fred's, Inc. (NASDAQ:FRED), Arena...
Sep 27, 2018 04:01 pm ET
Accelerate Diagnostics announces resignation of Joan Martin as Head of Europe, Middle East, and Africa
TUCSON, Ariz., Sept. 27, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that Joan Martin resigned from his position as Executive Vice President and Head of Europe, Middle East, and Africa and will be leaving the company for personal reasons....
Aug 08, 2018 07:45 am ET
Report: Developing Opportunities within CMS Energy, International Paper, IBERIABANK, Accelerate Diagnostics, El Paso Electric, and FTI Consulting — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CMS Energy Corporation (NYSE:CMS), International Paper Company (NYSE:IP),...
Aug 07, 2018 07:50 am ET
Accelerate Diagnostics Receives New Innovative Technology Contract from Vizient for the Accelerate Pheno™ System
TUCSON, Ariz., Aug. 7, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that it received an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the United States. The contract was based on a recommendation of the Accelerate Pheno™ system by hospital experts in this category who serve on one of Vizient's member-led councils.  Innovative Technology contracts are reserved for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organization's care de...
Aug 06, 2018 04:01 pm ET
Accelerate Diagnostics reports Q2 2018 financial results
TUCSON, Ariz., Aug. 6, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending June 30, 2018.  The company posted revenue of $1.7 million, up 142% from the prior year quarter, and reported a record number of new agreements signed in the quarter bringing the global total to 430 instruments. Contracts for customer evaluations total 312 instruments while commercial placements grew to 118 across the U.S., European, and Middle East regions. ...
Jul 19, 2018 02:30 pm ET
Accelerate Diagnostics to Review Second Quarter 2018 Results on August 6th
Accelerate Diagnostics, Inc. announced today it will host a conference call on Monday, August 6, 2018 to review the company’s second quarter 2018 financial results and commercial progress. President and Chief Executive Officer, Lawrence Mehren,...
Jun 05, 2018 11:30 am ET
Accelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the William Blair 38th Annual Growth Stock Conference in Chicago, Illinois on Wednesday, June 13, 2018 at 2:40 PM,...
May 09, 2018 04:03 pm ET
Accelerate Diagnostics reports Q1 2018 financial results
Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018.  The company generated revenue of $801,000, up 51% from the prior year, and reported signed agreements for 345 instruments. Contracts for customer...
May 04, 2018 07:35 am ET
Report: Developing Opportunities within US Ecology, Universal Health Realty Income Trust, Accelerate Diagnostics, Chesapeake Lodging Trust, Super Micro Computer, and Choice Hotels International — Futu
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of US Ecology, Inc. (NASDAQ:ECOL), Universal Health Realty Income Trust...
Apr 30, 2018 10:42 am ET
Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th
TUCSON, Ariz., April 30, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 9, 2018 to review its first quarter 2018 financial results and commercial progress.
Apr 21, 2018 03:37 am ET
Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
Four integrated symposium sessions, 11 poster presentations, and case studies will cover the clinical value of integrating diagnostic stewardship into current sepsis protocols given the rising rates of antibiotic resistance
Mar 23, 2018 02:15 am ET
Accelerate Diagnostics, Inc. Announces Pricing of $150 Million Convertible Notes Offering
TUCSON, Ariz., March 23, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate Diagnostics”) (NASDAQ:AXDX) today announced the pricing of $150.0 million aggregate principal amount of 2.50% convertible senior notes due 2023 (the “notes”) in a private placement to...
Mar 22, 2018 07:08 am ET
Accelerate Diagnostics Inc. Announces $150 Million Convertible Notes Offering
TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced its intention to offer, subject to market conditions and other factors, $150.0 million aggregate principal amount of convertible senior notes due 2023 (the “notes”)...
Mar 02, 2018 08:15 am ET
Report: Exploring Fundamental Drivers Behind Accelerate Diagnostics, FTI Consulting, Spark Therapeutics, Achaogen, Oxford Industries, and Kronos Worldwide — New Horizons, Emerging Trends, and Upcoming
NEW YORK, March 02, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Accelerate Diagnostics, Inc. (NASDAQ:AXDX), FTI Consulting,...
Feb 15, 2018 04:05 pm ET
Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
TUCSON, Ariz., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017. The company reported revenue for Q4 of $2.1 million, doubling revenue for the...
Feb 08, 2018 05:25 pm ET
Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
TUCSON, Ariz., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. will host a conference call on Thursday, February 15, 2018 to review its fourth quarter and full-year financial results for 2017.
Jan 10, 2018 07:57 am ET
Accelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4
TUCSON, Ariz., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of its latest assay for the Accelerate Pheno™ system targeting...
Jan 08, 2018 07:40 am ET
New Research Coverage Highlights ConnectOne, Rockwell Medical, Accelerate Diagnostics, Eleven Biotherapeutics, Renasant, and Natera — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ConnectOne Bancorp, Inc. (NASDAQ:CNOB), Rockwell Medical,...
Jan 04, 2018 01:44 pm ET
Accelerate Diagnostics to Present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco
TUCSON, Ariz., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation...
Nov 27, 2017 06:27 pm ET
Accelerate Diagnostics Joins Sepsis Alliance in Global #GivingTuesday Movement to Raise Awareness of Sepsis as Medical Emergency
TUCSON, Ariz., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. has teamed up with Sepsis Alliance for #GivingTuesday, November 28th, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage...
Nov 16, 2017 12:06 pm ET
Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors
TUCSON, Ariz., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the election of Charles Watts, M.D. to the company’s board of directors. His appointment is effective November 14, 2017.
Nov 15, 2017 08:30 am ET
Accelerate Diagnostics to Present at the 29th Annual Piper Jaffray Healthcare Conference in New York City
TUCSON, Ariz., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Lawrence Mehren, president and chief executive officer of Accelerate Diagnostics, is scheduled to present at the 29th Annual Piper Jaffray Healthcare Conference in New York City on Tuesday, November 28,...
Nov 02, 2017 04:01 pm ET
Accelerate Diagnostics reports Q3 2017 financial results
TUCSON, Ariz., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending September 30, 2017.  The company further reported signed agreements for 295 instruments year to date; contracts for customer...
Jul 18, 2017 05:38 pm ET
Accelerate Diagnostics Schedules Call to Review Second Quarter 2017 Results for August 3rd
TUCSON, Ariz., July 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Thursday, August 3, 2017 to discuss its second quarter 2017 financial results and commercial progress....
Jun 07, 2017 06:06 pm ET
Accelerate Diagnostics to Present at the 37th Annual Growth Stock Conference hosted by William Blair & Company
TUCSON, Ariz., June 07, 2017 (GLOBE NEWSWIRE) -- Lawrence Mehren, president and chief executive officer of Accelerate Diagnostics, will present at the 37th Annual Growth Stock Conference hosted by William Blair & Company in Chicago on Wednesday, June 14, 2017, at 04:00 PM Central Time....
May 15, 2017 05:14 pm ET
Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
TUCSON, Ariz., May 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock today, upsized from the original share offering of 2,500,000 shares of common stock, at a previously disclosed public offering price of $28.85 per share. The gross proceeds to Accelerate Diagnostics from the offering are approximately $79.3 million before deducting underwriting commissions and discounts, and estimated offering expenses payable by the company. In addition, Accelerate Di...
May 09, 2017 09:59 pm ET
Accelerate Diagnostics Announces Pricing of Upsized Public Offering of Common Stock
TUCSON, Ariz., May 09, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced the pricing of an underwritten public offering of 2,750,000 shares of its common stock, upsized from the original share offering of 2,500,000 shares of common stock, at a price to the public of $28.85 per share. All of the shares are being sold by Accelerate Diagnostics. The gross proceeds to Accelerate Diagnostics from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $79.3 million. The offering...
May 08, 2017 04:14 pm ET
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
TUCSON, Ariz., May 08, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced that it has commenced an underwritten public offering of 2,500,000 shares of its common stock. All of the shares are being offered by Accelerate Diagnostics. In addition, Accelerate Diagnostics expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 375,000 shares of its common stock at the public offering price, less the underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance...
May 03, 2017 04:05 pm ET
Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017
TUCSON, Ariz., May 03, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation contracts covering 169 instruments, 22 additional instruments converted into revenue generating placements, and revenue growth exceeding 325% of the same period in the prior year....
Feb 23, 2017 09:45 pm ET
Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples. The blood culture kit is indicated for susceptibility testing of specific pathogenic bacteria commonly associated with bacteremia, the leading cause of sepsis....
Feb 23, 2017 04:19 pm ET
Accelerate Diagnostics to Report Preliminary Fourth Quarter and Full Year 2016 Results on February 27th
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced it will report preliminary fourth-quarter and full year 2016 financial results on Monday, February 27th, 2017....
Nov 22, 2016 01:58 pm ET
Accelerate Diagnostics to Present at the Piper Jaffray 28th Annual Healthcare Conference on November 30th
TUCSON, Ariz., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer, is scheduled to present at the Piper Jaffray 28th Annual Healthcare Conference in New York City, NY on Wednesday, November 30th at 2:00 PM EST....
Oct 21, 2016 05:45 pm ET
Accelerate Diagnostics to Report Third-Quarter 2016 Results on November 9th
TUCSON, Ariz., Oct. 21, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report third-quarter 2016 financial results on Wednesday, November 9, 2016....
Jul 22, 2016 08:15 am ET
Accelerate Diagnostics to Report Second-Quarter 2016 Results on August 8
TUCSON, Ariz., July 22, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report second-quarter 2016 financial results on Monday, August 8th....
Jul 11, 2016 05:00 am ET
Accelerate Diagnostics Submits De Novo Request to FDA for Accelerate Pheno™ System and Accelerate PhenoTest™ BC kit
TUCSON, Ariz., July 11, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate”) announced today the submission of a De Novo request for Evaluation of Automatic Class III Designation to the U.S. Food and Drug Administration (FDA) for its Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for positive blood culture samples.  ...
Jun 14, 2016 07:57 pm ET
Accelerate Diagnostics Completes Clinical Data Collection, Will Present Data at the William Blair 36th Annual Growth Stock Conference
TUCSON, Ariz., June 14, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate”) announced today the completion of clinical data collection intended for submission to the FDA in conjunction with its de novo 510k request for premarket clearance of the Accelerate Pheno™ system and Accelerate Pheno™ BC kit for positive blood cultures. An overview of the data collected will be included in the previously announced presentation at the William Blair 36th Annual Growth Stock Conference. The Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit were formerly referred to in generic ter...
Jun 07, 2016 07:06 pm ET
Accelerate Diagnostics to Present at the 36th Annual Growth Stock Conference
TUCSON, Ariz., June 07, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, the company’s president and chief executive officer, is scheduled to present to investors at the 36th Annual Growth Stock Conference hosted by William Blair & Company, L.L.C. on June 15, 2016 at 8:00 a.m. Central Time at the Four Seasons Hotel in Chicago, Illinois. The presentation will be accessible from the investor portal of the company’s website at http://ir.axdx.com....
Feb 11, 2016 09:31 am ET
Covered Call Alerts For Twitter, Akamai Technologies, Criteo SA, Accelerate Diagnostics and Peabody Energy Released By InvestorsObserver
CHICAGO, Feb. 11, 2016 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TWTR, AKAM, CRTO, AXDX and BTU....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.